Outcomes of postnatal systemic corticosteroids administration in ventilated preterm newborns: a systematic review of randomized controlled trials
- PMID: 38419972
- PMCID: PMC10899705
- DOI: 10.3389/fped.2024.1344337
Outcomes of postnatal systemic corticosteroids administration in ventilated preterm newborns: a systematic review of randomized controlled trials
Abstract
Introduction: Prolonged mechanical ventilation, commonly used to assist preterm newborns, increases the risk of developing bronchopulmonary dysplasia (BPD). In recent decades, studies have demonstrated that systemic corticosteroids play a significant role in the prevention and management of BPD. In this systematic review of randomized controlled trials (RCTs), we evaluated the association between the administration of systemic corticosteroids in preterm infants and its long-term outcomes, such as neurodevelopment, growth, extubation rate, and related adverse effects.
Methods: We conducted an electronic search in Medline, Scopus, and PubMed using the following terms: "premature infants" and "corticosteroids." We considered all RCTs published up to June 2023 as eligible. We included all studies involving preterm newborns treated with systemic corticosteroids and excluded studies on inhaled corticosteroids.
Results: A total of 39 RCTs were evaluated. The influence of steroids administered systemically during the neonatal period on long-term neurological outcomes remains unknown, with no influence observed for long-term growth. The postnatal administration of systemic corticosteroids has been found to reduce the timing of extubation and improve respiratory outcomes. Dexamethasone appears to be more effective than hydrocortisone, despite causing a higher rate of systemic hypertension and hyperglycemia. However, in the majority of RCTs analyzed, there were no differences in the adverse effects related to postnatal corticosteroid administration.
Conclusion: Dexamethasone administered during the neonatal period appears to be more effective than hydrocortisone in terms of respiratory outcomes; however, caution should be taken when administering dexamethasone. Data derived from current evidence, including meta-analyses, are inconclusive on the long-term effects of the administration of systemic steroids in preterm infants or the possibility of neurodevelopmental consequences.
Keywords: dexamethasone; extubation; growth; hydrocortisone; hyperglycemia; neurodevelopment; pulmonary outcome; systemic hypertension.
© 2024 Boscarino, Cardilli, Conti, Liguori, Repole, Parisi and Terrin.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures



Similar articles
-
[The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].Arch Pediatr. 2010 Oct;17(10):1480-7. doi: 10.1016/j.arcped.2010.07.013. Epub 2010 Sep 22. Arch Pediatr. 2010. PMID: 20864322 French.
-
Systemic Postnatal Corticosteroids, Bronchopulmonary Dysplasia, and Survival Free of Cerebral Palsy.JAMA Pediatr. 2025 Jan 1;179(1):65-72. doi: 10.1001/jamapediatrics.2024.4575. JAMA Pediatr. 2025. PMID: 39556404
-
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5. Neonatology. 2015. PMID: 26044104 Review.
-
Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis.JAMA Pediatr. 2021 Jun 1;175(6):e206826. doi: 10.1001/jamapediatrics.2020.6826. Epub 2021 Jun 7. JAMA Pediatr. 2021. PMID: 33720274 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
Cited by
-
Neonatal Sepsis: A Comprehensive Review.Antibiotics (Basel). 2024 Dec 25;14(1):6. doi: 10.3390/antibiotics14010006. Antibiotics (Basel). 2024. PMID: 39858292 Free PMC article. Review.
-
Salivary cortisol is not associated with dexamethasone response in preterm infants with evolving bronchopulmonary dysplasia.J Perinatol. 2024 Nov 21. doi: 10.1038/s41372-024-02177-x. Online ahead of print. J Perinatol. 2024. PMID: 39567652
-
Unveiling the Emerging Role of Extracellular Vesicle-Inflammasomes in Hyperoxia-Induced Neonatal Lung and Brain Injury.Cells. 2024 Dec 18;13(24):2094. doi: 10.3390/cells13242094. Cells. 2024. PMID: 39768185 Free PMC article. Review.
-
Perinatal glucocorticoid sensitivity in the preterm newborn: molecular mechanisms, endogenous determinants, and clinical implications.Front Endocrinol (Lausanne). 2025 Jul 16;16:1587891. doi: 10.3389/fendo.2025.1587891. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40741174 Free PMC article. Review.
References
-
- World Health Organization. Survive and thrive: transforming care for every small and sick newborn. (2019). Available online at: https://www.unicef.org/reports/transforming-care-for-every-small-and-sic... (accessed May 2020).
Publication types
LinkOut - more resources
Full Text Sources